LIPELLA PHARMACEUTICALS CEO Jonathan Kaufman's 2023 pay jumps 76% to $323K
LIPELLA PHARMACEUTICALS reports 2023 executive compensation
By ExecPay News
Published: August 12, 2024
LIPELLA PHARMACEUTICALS reported fiscal year 2023 executive compensation information on August 12, 2024.
In 2023, three executives at LIPELLA PHARMACEUTICALS received on average a compensation package of $299K, a 111% increase compared to previous year.
Average pay of disclosed executives at LIPELLA PHARMACEUTICALS
Jonathan Kaufman, Chief Executive Officer, received $323K in total, which increased by 76% compared to 2022. 63% of Kaufman's compensation, or $204K, was in salary. Kaufman also received $119K in option awards.
Michael Chancellor, Chief Medical Officer, received a compensation package of $315K, which increased by 80% compared to previous year. 62% of the compensation package, or $196K, was in salary.
Douglas Johnston, Chief Financial Officer, earned $260K in 2023, a 285% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on August 12, 2024.